AAPL323.81+8.47 (+2.69%) ▲|ABBV252.61+1.70 (+0.68%) ▲|ABT103.82-1.42 (-1.34%) ▼|ACN177.64+1.84 (+1.05%) ▲|ADBE249.37-5.49 (-2.15%) ▼|AMAT457.63-11.22 (-2.39%) ▼|AMD506.42-14.68 (-2.82%) ▼|AMGN382.73-8.54 (-2.18%) ▼|AMT172.86-2.57 (-1.47%) ▼|AMZN252.26-0.15 (-0.06%) ▼|AVGO362.82-1.56 (-0.43%) ▼|AXP320.69-1.12 (-0.35%) ▼|BA206.24-0.18 (-0.09%) ▼|BAC62.40-0.28 (-0.44%) ▼|BKNG175.74+2.31 (+1.33%) ▲|BLK1,069.35-2.69 (-0.25%) ▼|BMY63.95-0.46 (-0.71%) ▼|BNY162.29-0.22 (-0.14%) ▼|BRK-B504.93-1.79 (-0.35%) ▼|C137.99+0.19 (+0.14%) ▲|CAT802.09-13.48 (-1.65%) ▼|CL88.23+0.20 (+0.23%) ▲|CMCSA25.15+0.56 (+2.26%) ▲|COF207.55-3.31 (-1.57%) ▼|COP137.88+1.35 (+0.99%) ▲|COST899.44-3.16 (-0.35%) ▼|CRM244.04-0.12 (-0.05%) ▼|CSCO108.19-1.24 (-1.13%) ▼|CVS95.24-0.14 (-0.15%) ▼|CVX213.52-0.30 (-0.14%) ▼|DE674.07-3.14 (-0.46%) ▼|DHR201.69-3.17 (-1.55%) ▼|DIS104.89+0.71 (+0.68%) ▲|DUK119.64-0.80 (-0.66%) ▼|EMR147.52-2.83 (-1.88%) ▼|FDX311.06+1.87 (+0.60%) ▲|GD353.48+0.81 (+0.23%) ▲|GE322.87-2.55 (-0.78%) ▼|GEV925.75-25.29 (-2.66%) ▼|GILD145.05-0.60 (-0.41%) ▼|GM85.49+1.73 (+2.07%) ▲|GOOG329.31+0.93 (+0.28%) ▲|GOOGL331.57+0.92 (+0.28%) ▲|GS1,020.01-8.77 (-0.85%) ▼|HD305.21-5.24 (-1.69%) ▼|HON202.18-2.76 (-1.34%) ▼|IBM236.33-3.62 (-1.51%) ▼|INTC101.37-4.87 (-4.58%) ▼|INTU312.62-1.32 (-0.42%) ▼|ISRG360.15+6.91 (+1.96%) ▲|JNJ266.75-0.34 (-0.13%) ▼|JPM352.80-1.91 (-0.54%) ▼|KO88.14+0.59 (+0.67%) ▲|LIN461.61-5.05 (-1.08%) ▼|LLY1,126.61+2.40 (+0.21%) ▲|LMT528.21+3.75 (+0.72%) ▲|LOW195.79-2.82 (-1.42%) ▼|LRCX300.79-15.05 (-4.77%) ▼|MA564.19-3.32 (-0.58%) ▼|MCD253.70+0.22 (+0.08%) ▲|MDLZ62.26-0.16 (-0.26%) ▼|MDT91.36-0.53 (-0.58%) ▼|META649.75-3.94 (-0.60%) ▼|MMM162.34-2.06 (-1.25%) ▼|MO68.67+0.78 (+1.14%) ▲|MRK145.04-2.50 (-1.69%) ▼|MS213.84-1.51 (-0.70%) ▼|MSFT492.38+0.73 (+0.15%) ▲|MU979.91-47.87 (-4.66%) ▼|NEE82.55-0.10 (-0.12%) ▼|NFLX75.99-0.05 (-0.06%) ▼|NKE36.81-0.54 (-1.45%) ▼|NOW131.94+0.83 (+0.63%) ▲|NVDA218.46-5.21 (-2.33%) ▼|ORCL156.58-5.05 (-3.12%) ▼|PEP136.89+0.20 (+0.15%) ▲|PFE27.51-0.28 (-0.99%) ▼|PG142.91+0.27 (+0.19%) ▲|PLTR166.14-3.39 (-2.00%) ▼|PM189.15+3.44 (+1.85%) ▲|QCOM180.12+3.72 (+2.11%) ▲|RTX197.41-0.14 (-0.07%) ▼|SBUX99.65-0.39 (-0.39%) ▼|SCHW106.74+0.20 (+0.18%) ▲|SO87.91-0.44 (-0.49%) ▼|SPG205.94+1.41 (+0.69%) ▲|T25.53+0.38 (+1.49%) ▲|TMO603.01-2.68 (-0.44%) ▼|TMUS175.87-1.47 (-0.83%) ▼|TSLA366.60-1.21 (-0.33%) ▼|TXN259.47-2.12 (-0.81%) ▼|UBER72.45+1.37 (+1.93%) ▲|UNH390.92-2.14 (-0.54%) ▼|UNP284.23-0.52 (-0.18%) ▼|UPS100.08+0.86 (+0.86%) ▲|USB62.01-0.11 (-0.17%) ▼|V366.59-0.80 (-0.22%) ▼|VZ49.92+0.18 (+0.36%) ▲|WFC88.94-0.74 (-0.82%) ▼|WMT105.89+0.06 (+0.05%) ▲|XOM165.42+1.19 (+0.72%) ▲|AAPL323.81+8.47 (+2.69%) ▲|ABBV252.61+1.70 (+0.68%) ▲|ABT103.82-1.42 (-1.34%) ▼|ACN177.64+1.84 (+1.05%) ▲|ADBE249.37-5.49 (-2.15%) ▼|AMAT457.63-11.22 (-2.39%) ▼|AMD506.42-14.68 (-2.82%) ▼|AMGN382.73-8.54 (-2.18%) ▼|AMT172.86-2.57 (-1.47%) ▼|AMZN252.26-0.15 (-0.06%) ▼|AVGO362.82-1.56 (-0.43%) ▼|AXP320.69-1.12 (-0.35%) ▼|BA206.24-0.18 (-0.09%) ▼|BAC62.40-0.28 (-0.44%) ▼|BKNG175.74+2.31 (+1.33%) ▲|BLK1,069.35-2.69 (-0.25%) ▼|BMY63.95-0.46 (-0.71%) ▼|BNY162.29-0.22 (-0.14%) ▼|BRK-B504.93-1.79 (-0.35%) ▼|C137.99+0.19 (+0.14%) ▲|CAT802.09-13.48 (-1.65%) ▼|CL88.23+0.20 (+0.23%) ▲|CMCSA25.15+0.56 (+2.26%) ▲|COF207.55-3.31 (-1.57%) ▼|COP137.88+1.35 (+0.99%) ▲|COST899.44-3.16 (-0.35%) ▼|CRM244.04-0.12 (-0.05%) ▼|CSCO108.19-1.24 (-1.13%) ▼|CVS95.24-0.14 (-0.15%) ▼|CVX213.52-0.30 (-0.14%) ▼|DE674.07-3.14 (-0.46%) ▼|DHR201.69-3.17 (-1.55%) ▼|DIS104.89+0.71 (+0.68%) ▲|DUK119.64-0.80 (-0.66%) ▼|EMR147.52-2.83 (-1.88%) ▼|FDX311.06+1.87 (+0.60%) ▲|GD353.48+0.81 (+0.23%) ▲|GE322.87-2.55 (-0.78%) ▼|GEV925.75-25.29 (-2.66%) ▼|GILD145.05-0.60 (-0.41%) ▼|GM85.49+1.73 (+2.07%) ▲|GOOG329.31+0.93 (+0.28%) ▲|GOOGL331.57+0.92 (+0.28%) ▲|GS1,020.01-8.77 (-0.85%) ▼|HD305.21-5.24 (-1.69%) ▼|HON202.18-2.76 (-1.34%) ▼|IBM236.33-3.62 (-1.51%) ▼|INTC101.37-4.87 (-4.58%) ▼|INTU312.62-1.32 (-0.42%) ▼|ISRG360.15+6.91 (+1.96%) ▲|JNJ266.75-0.34 (-0.13%) ▼|JPM352.80-1.91 (-0.54%) ▼|KO88.14+0.59 (+0.67%) ▲|LIN461.61-5.05 (-1.08%) ▼|LLY1,126.61+2.40 (+0.21%) ▲|LMT528.21+3.75 (+0.72%) ▲|LOW195.79-2.82 (-1.42%) ▼|LRCX300.79-15.05 (-4.77%) ▼|MA564.19-3.32 (-0.58%) ▼|MCD253.70+0.22 (+0.08%) ▲|MDLZ62.26-0.16 (-0.26%) ▼|MDT91.36-0.53 (-0.58%) ▼|META649.75-3.94 (-0.60%) ▼|MMM162.34-2.06 (-1.25%) ▼|MO68.67+0.78 (+1.14%) ▲|MRK145.04-2.50 (-1.69%) ▼|MS213.84-1.51 (-0.70%) ▼|MSFT492.38+0.73 (+0.15%) ▲|MU979.91-47.87 (-4.66%) ▼|NEE82.55-0.10 (-0.12%) ▼|NFLX75.99-0.05 (-0.06%) ▼|NKE36.81-0.54 (-1.45%) ▼|NOW131.94+0.83 (+0.63%) ▲|NVDA218.46-5.21 (-2.33%) ▼|ORCL156.58-5.05 (-3.12%) ▼|PEP136.89+0.20 (+0.15%) ▲|PFE27.51-0.28 (-0.99%) ▼|PG142.91+0.27 (+0.19%) ▲|PLTR166.14-3.39 (-2.00%) ▼|PM189.15+3.44 (+1.85%) ▲|QCOM180.12+3.72 (+2.11%) ▲|RTX197.41-0.14 (-0.07%) ▼|SBUX99.65-0.39 (-0.39%) ▼|SCHW106.74+0.20 (+0.18%) ▲|SO87.91-0.44 (-0.49%) ▼|SPG205.94+1.41 (+0.69%) ▲|T25.53+0.38 (+1.49%) ▲|TMO603.01-2.68 (-0.44%) ▼|TMUS175.87-1.47 (-0.83%) ▼|TSLA366.60-1.21 (-0.33%) ▼|TXN259.47-2.12 (-0.81%) ▼|UBER72.45+1.37 (+1.93%) ▲|UNH390.92-2.14 (-0.54%) ▼|UNP284.23-0.52 (-0.18%) ▼|UPS100.08+0.86 (+0.86%) ▲|USB62.01-0.11 (-0.17%) ▼|V366.59-0.80 (-0.22%) ▼|VZ49.92+0.18 (+0.36%) ▲|WFC88.94-0.74 (-0.82%) ▼|WMT105.89+0.06 (+0.05%) ▲|XOM165.42+1.19 (+0.72%) ▲|
30.6 C
New York
Thursday, September 10, 2026

Tag: treatments

newssourceFORcompanyinformationcontent1releasesmarket

START and Advarra Unite to Deliver Unmatched Speed, Quality, and Predictability for Early-Phase Oncology Trials

START enhances its global leadership by integrating Advarra's advanced regulatory and technology solutions, creating a seamlessly connected site network to accelerate trials and relieve...

Johnson & Johnson showcases latest advancements in Alzheimer’s research at AAIC 2025

Early data from robust Autonomy Phase 2b posdinemab trial demonstrate Company's leadership in multimodal biomarkers and early detection New findings highlight the central role of...

Electro-Oxidation Market worth $2.1 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., July 24, 2025 /PRNewswire/ -- The report "Electro-Oxidation Market by Type (Direct Electro-Oxidation, Indirect Electro-Oxidation), Electrode Material (Boron-Doped Diamond (BBD), Lead...

Electro-Oxidation Market worth $2.1 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., July 24, 2025 /PRNewswire/ -- The report "Electro-Oxidation Market by Type (Direct Electro-Oxidation, Indirect Electro-Oxidation), Electrode Material (Boron-Doped Diamond (BBD), Lead...

LUNGevity Foundation Joins 2025 LungXperience Tour to Promote Lung Health and Early Detection Across the U.S.

Organization to Participate in 12 National Events as Part of Innovative Health Education Initiative WASHINGTON, July 24, 2025 /PRNewswire/ -- LUNGevity Foundation, the nation's leading...

Aicuris Enrolled Last Participant in Pivotal Trial with Pritelivir to Treat Refractory Herpes Simplex Infection in Immunocompromised Patients

Wuppertal, Germany, July 24, 2025 - Aicuris Anti-infective Cures AG today announced the completion of patient enrollment in its pivotal Phase 3 trial, PRIOH-1, evaluating pritelivir for the treatment of refractory and/or treatment resistant herpes simplex virus (HSV) infections in immunocompromised patients. The company’s lead candidate is a small molecule specifically inhibiting the viral helicase-primase complex, which represents a novel mechanism of action distinct from current HSV therapies.

Introducing Inner Harmony Spa Sg presenting Singapore’s best facials, massages, energy healing treatments in CBD

SINGAPORE, July 23, 2025 (GLOBE NEWSWIRE) -- Tucked away in the lively North Bridge district, Inner Harmony is a sanctuary of wellness—blending Asian traditions with European spa innovations to deliver transformative experiences. Whether one is seeking relaxation or rejuvenation, their comprehensive suite of services caters thoughtfully to every wellness need.

PFPFA Malaysia Officially Launched, Marking Next Chapter in SingWealth Holdings’ Regional Growth

With the launch of PFPFA (Malaysia), SingWealth Holdings deepens its regional presence and strengthens its commitment to delivering trusted, client-centric financial advisory solutions across...

Akeso Announces First Patient Enrollment in Phase III Trial of Ivonescimab for Pancreatic Cancer

HONG KONG, July 23, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been...

Local Plastic Surgeon in Paramus New Jersey, Dr. Andrew Nouri Educates Patients on Insurance Coverage for Medically Necessary Breast Reduction

Paramus, NJ, July 23, 2025 (GLOBE NEWSWIRE) -- For many women, large breasts are not just a cosmetic concern, they’re a medical one. Chronic back, neck, and shoulder pain, rashes under the breasts, painful grooves from bra straps, posture problems, and even emotional distress are just some of the symptoms that can come with disproportionately large breasts.

Children’s Miracle Network Hospitals’ Ignite: Inspiring This Generation to Lift Up the Next Through Impactful Leadership

Annual Peer-to-Peer Leadership Conference Unites Student Leaders and Hospital Advisors to Strengthen Dance Marathon Programs Nationwide ST. LOUIS, July 23, 2025 /PRNewswire/ -- Children's Miracle...

Scaling Self-Care Can Be a Game-Changer in Global Fight Against Non-Communicable Diseases

Ahead of the upcoming UN General Assembly to set a new vision for non-communicable diseases, the Global Self-Care Federation is calling for self-care strategies...

Scaling Self-Care Can Be a Game-Changer in Global Fight Against Non-Communicable Diseases

Ahead of the upcoming UN General Assembly to set a new vision for non-communicable diseases, the Global Self-Care Federation is calling for self-care strategies...

Scaling Self-Care Can Be a Game-Changer in Global Fight Against Non-Communicable Diseases

Ahead of the upcoming UN General Assembly to set a new vision for non-communicable diseases, the Global Self-Care Federation is calling for self-care strategies...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTreatments

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers